INTERNATIONAL PATENT: KIOX PHARMACEUTICALS APS FILES APPLICATION FOR "INHALABLE FORMULATIONS OF RUXOLITINIB, METHODS OF MANUFACTURE AND USES THEREOF"

GENEVA, Aug. 4 -- KIOX PHARMACEUTICALS APS (Stolbjergvej 26C3070 Snekkersten) filed a patent application (PCT/EP2025/051643) for "INHALABLE FORMULATIONS OF RUXOLITINIB, METHODS OF MANUFACTURE AND USES THEREOF" on Jan 23, 2025. With publication no. WO/2025/157904, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WALMAR, Mikkel (c/o Kiox Pharmaceuticals ApSStolbjergvej 26C3070 Snekkersten)

Abstract: There is provided inhalable formulations of ruxolitinib, manufacture, and uses thereof.

For more information:https://pate...